The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...
Reports Q4 revenue $165.0M, consensus $164.98M. “In 2024, we launched major new products across all three of our platforms and we made changes ...
BofA analyst Michael Ryskin lowered the firm’s price target on 10x Genomics (TXG) to $16 from $20 and keeps a Neutral rating on the shares ...
Genomics is the study of the full genetic complement of an organism (the genome). It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the ...
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...
Medical genomics is the application and integration of genomic and other data—including functional genomics, genome structure, genome-scale population genetics, epigenomics, proteomics ...
After hours: February 13 at 4:05:01 PM EST Loading Chart for OMIC ...
Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results